XOMA Royalty (XOMA) Common Equity (2010 - 2026)

XOMA Royalty (XOMA) reported Common Equity of $92.9 million for Q1 2026, up 43.75% on a YoY basis from $64.6 million in Q1 2025, and up 10.64% sequentially from $83.9 million in Q4 2025.

XOMA Royalty (XOMA) Common Equity (2010 - 2026) Analysis & Trends

XOMA Royalty (XOMA) has 17 years of Common Equity data on file, last reported at $92.9 million in Q1 2026.

  • For the quarter ending Q1 2026, Common Equity rose 43.75% year-over-year to $92.9 million; the trailing twelve-month figure through Mar 2026 stood at $92.9 million (up 43.75% YoY), and the FY2025 full-year result was $83.9 million, up 35.6% from the prior year.
  • Common Equity rose to $92.9 million in Q1 2026, from $83.9 million in the prior quarter.
  • In the past five years, Common Equity ranged from a high of $139.9 million in Q1 2022 to a low of $61.9 million in Q4 2024.
  • A 5-year average of $94.5 million and a median of $88.4 million in 2025 frame the typical range for Common Equity.
  • Across the five-year window, Common Equity jumped 71.22% in 2022 and plunged 45.58% in 2024, its largest moves.
  • Tracing XOMA's Common Equity over 5 years: stood at $124.0 million in 2022, then sank by 44.6% to $68.7 million in 2023, then retreated by 9.9% to $61.9 million in 2024, then soared by 35.6% to $83.9 million in 2025, then grew by 10.64% to $92.9 million in 2026.
  • Business Quant data shows XOMA's Common Equity at $92.9 million in Q1 2026, $83.9 million in Q4 2025, and $72.4 million in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Common Equity (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 251.12 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -98.34 Mn
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 4.76 Bn
4 NuCana 279.75 Bn 279.75 Bn - 32.36 Mn
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 19.36 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 31.42 Bn
7 Belite Bio 62.51 Bn 62.51 Bn - 795.79 Mn
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - 1.50 Bn
10 XOMA Royalty 478.42 Mn 412.34 Mn - 92.88 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 92.88 Mn
Dec 31, 2025 83.94 Mn
Jun 30, 2025 72.44 Mn
Mar 31, 2025 64.61 Mn
Dec 31, 2024 61.90 Mn
Sep 30, 2024 64.79 Mn
Jun 30, 2024 79.97 Mn
Mar 31, 2024 62.32 Mn
Dec 31, 2023 68.70 Mn
Sep 30, 2023 105.96 Mn
Jun 30, 2023 110.12 Mn
Mar 31, 2023 114.53 Mn
Dec 31, 2022 124.01 Mn
Sep 30, 2022 130.33 Mn
Jun 30, 2022 134.96 Mn
Mar 31, 2022 139.92 Mn
Dec 31, 2021 141.88 Mn
Sep 30, 2021 111.58 Mn
Jun 30, 2021 116.58 Mn
Mar 31, 2021 81.72 Mn